Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/222842
Title: | Unmet needs in hereditary angioedema: an international survey of physicians |
Author: | Buttgereit, Thomas Aulenbacher, Felix Adatia, Adil Vera Ayala, Carolina Ali Al-nesf, Maryam Altrichter, Sabine Abuzakouk, Mohamed Al-ahmad, Mona Mohammed Ali, Ramzy Berardi, Alejandro Boccon-gibod, Isabelle Bouillet, Laurence Brussino, Luisa Barešić, Marko J. Busse, Paula D. Betschel, Stephen Chong-neto, Herberto Calderón Llosa, Oscar J. Craig, Timothy D. Dorr, Anthony Duarte Dortas Junior, Sérgio Fomina, Daria Farkas, Henriette Shen Fok, Jie S. Grumach, Anete Greve, Jens Guilarte, Mar Gonçalo, Margarida Grivcheva-panovska, Vesna Hide, Michihiro Hakl, Roman Jindal, Ankur H. Katelaris, Constance Kamaleswaran, Shailajah Kinaciyan, Tamar Latysheva, Elena Ignacio Larco Sousa, José Lleonart Bellfill, Ramón Mobayed, Hassan Metz, Martin Nasr, Iman T. Mitrevska, Natasa Nicola, Stefania Alberto Salvador Parisi, Claudio Porebski, Grzegorz Peter, Jonny Paes Leme Ferriani, Mariana Rosario Filho, Nelson Enis Şekerel, Bülent Sarquis Serpa, Faradiba Stobiecki, Marcin Trainotti, Susanne Valerieva, Anna Wongsa, Chamard C. Y. Wong, Jane Yucel, Esra Li, Yinglei Nenci, Chiara Maurer, Marcus Magerl, Markus H. Li, Philip |
Issue Date: | 28-Jul-2025 |
Publisher: | Springer Science and Business Media LLC |
Abstract: | BackgroundHereditary angioedema (HAE) is a rare and potentially life-threatening genetic disorder characterized by unpredictable attacks of angioedema. MENTALIST (UnMEt Needs in herediTAry angioedema-a gLobal physIcian perSpecTive) is the first international survey uncovering unmet needs and identifying barriers to optimal management in HAE following the latest update of the World Allergy Organization (WAO)/European Academy of Allergy and Clinical Immunology (EAACI) HAE guidelines.MethodsThis web-based survey comprised 24 questions on HAE management and unmet needs. HAE-expert physicians from the Angioedema Centers of Reference and Excellence network ranked unmet needs according to their own perspectives and their patients' perspectives, using a 10-point Likert scale ranging from 0 (not a challenge/unmet need at all) to 10 (huge challenge/unmet need).ResultsOf 64 respondents from 32 countries, most (91%) had > 5 years of experience in managing HAE. Overall, 48% of respondents (n = 31/64) reported that < 50% of their patients had achieved the WAO/EAACI HAE treatment goals of total disease control and normalization of life at the time of the survey. Implementation of consensus recommendations was found to be inconsistent across regions. Gaps in non-HAE-expert physician knowledge, treatment costs, and reimbursement for long-term prophylaxis were the highest-priority challenges according to the respondents. Burden of disease remains a challenge among patients, as reported by their physicians.ConclusionsThe MENTALIST findings highlight a need for removal of barriers to HAE treatment goals and propose a call to action to improve access to treatments, for greater provision of education for physicians and patients, critical collaboration with patient organizations and industry stakeholders and ultimately to optimize HAE care. |
Note: | Reproducció del document publicat a: https://doi.org/10.1186/s13023-025-03739-8 |
It is part of: | Orphanet Journal of Rare Diseases, 2025, vol. 20, issue. 1 |
URI: | https://hdl.handle.net/2445/222842 |
Related resource: | https://doi.org/10.1186/s13023-025-03739-8 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s13023-025-03739-8.pdf | 1.19 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.